ROP:SWX
Roche Holding AG Genussscheine
CHFÂ 404.70
arrow_downward
-0.44%(-1.80) 1D
Nov 13, 5:30:00 PM GMT+1 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ROP...
Open
CHFÂ 406.50
High
CHFÂ 406.50
Low
CHFÂ 402.30
Mkt. cap
328.49B
Avg. vol.
1.03M
Volume
858.30K
Dividend
2.42%
Quarterly dividend
CHFÂ 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
26.41
52-wk high
CHFÂ 407.60
52-wk low
CHFÂ 291.00
EPS
CHFÂ 15.33
Shares outstanding
702.56M
No. of employees
113K
Open
CHFÂ 406.50
High
CHFÂ 406.50
Low
CHFÂ 402.30
Mkt. cap
328.49B
Avg. vol.
1.03M
Volume
858.30K
Dividend
2.42%
Quarterly dividend
CHFÂ 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
26.41
52-wk high
CHFÂ 407.60
52-wk low
CHFÂ 291.00
EPS
CHFÂ 15.33
Shares outstanding
702.56M
No. of employees
113K
News stories
From web sources and news partners
Investing.com Nigeria
·
1 day ago
Roche receives EU committee backing for Gazyva in lupus treatment By Investing.com
Investing.com
·
1 day ago
Roche receives EU committee backing for Gazyva in lupus treatment
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in the Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees113K
FoundedOct 1, 1896
HeadquartersBasel, Basel City, Switzerland
SectorHealth Care
IndustryPharmaceutical industry
Websiteroche.com